CRISPR Therapeutics AG
看多

Consolidation and flagging - PT $115 at the 1.618 Fib extension

59
CRSP had a recent pop due to the Nobel prize announcement - after a little pullback and consolidation at these levels, it looks getting poised again to reach ATHs. Long price target $115 minimum. A great fundamental and technical set up. ARKK ETF's #2 position in their portfolio. A great disruptor in the genomics sector.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。